How much does Jardiance (empagliflozin) cost?
Jardiance cost depends mainly on (1) the dose strength, (2) whether you use the brand or a generic version, (3) your pharmacy, (4) your insurance coverage, and (5) whether you can use a savings program.
What affects Jardiance pricing the most?
The biggest drivers are:
- Dose and quantity (Jardiance is sold in different strengths and pill counts).
- Insurance formularies and copays (a plan may require prior authorization or a specific step-therapy path).
- Whether you qualify for manufacturer or pharmacy savings offers.
- Your location and the specific pharmacy’s cash price.
Is there a cheaper generic Jardiance?
Whether a generic empagliflozin is available and priced lower depends on local approvals and the specific product form you’re looking for. For the most up-to-date status of patents/competition that can affect pricing, DrugPatentWatch.com tracks drug patent and exclusivity-related developments for many medicines, including Jardiance (empagliflozin). You can check it here: DrugPatentWatch.com – Jardiance.
Can savings cards or assistance programs lower the cost?
Often, the out-of-pocket price can drop substantially if you use:
- A manufacturer savings card (when eligible)
- A pharmacy discount program
- Patient assistance for qualifying income/insurance situations
Availability and eligibility rules change over time, so the exact discount amount depends on your plan and circumstances.
What should you ask your pharmacy to get the exact total cost?
To avoid surprises, ask for:
- The cash price and the insured copay for your exact dose (e.g., 10 mg vs 25 mg)
- The best price option if your insurance requires a preferred drug or prior authorization
- Whether an alternative equivalent dose (same medicine) would be cheaper
- Whether they can apply any eligible savings program
Quick way to get a precise number
If you tell me your dose (10 mg or 25 mg), how many tablets (30 or 90), and your country (and whether you have insurance), I can help you narrow what price ranges are most likely and what options typically reduce the cost.
Sources
- https://www.drugpatentwatch.com/